LEKH POUDEL: Open Payments
NPI 1104677632 · NOTTINGHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $94 |
| Exact Sciences Corporation | 3 | $56 |
| Lilly USA, LLC | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $19 |
Products named: Cologuard Collection Kit, MOUNJARO, Ozempic, VAXELIS, BREZTRI, VYNDAQEL, NEXLETOL, ImmunoCAP.
Industry payments across MD — which companies pay providers there.
